UGT2B27P: A Drug Target / Disease Biomarker (G54569)

Target Name: UGT2B27P

NCBI ID: G54569

UGT2B27P

Other Name(s): UDP glucuronosyltransferase family 2 member B27, pseudogene

UGT2B27P: A Drug Target / Disease Biomarker

UGT2B27P is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 6 and encodes a protein known as UGT2B27P.

The UGT2B27P gene has been shown to play a role in the detoxification of xenobiotics, which are substances that can cause harm to the body. Xenobiotics include a wide variety of chemicals, such as drugs, solvents, and industrial waste products. Many of these substances are toxic to the human body and can cause a range of negative health effects, including cancer, neurotoxicity, and reproductive problems.

The UGT2B27P gene is thought to be involved in the detoxification of xenobiotics by the enzyme UGT2B27P. This enzyme is a key player in the detoxification process, and has been shown to be involved in the elimination of a wide variety of xenobiotics.

One of the ways that UGT2B27P is thought to work is by helping to remove the toxic metabolites of xenobiotics from the body. These metabolites can be highly toxic and can cause a range of negative health effects, including cancer, neurotoxicity, and reproductive problems. By helping to remove these metabolites, UGT2B27P may be able to reduce the risk of these negative health effects.

In addition to its role in the detoxification of xenobiotics, UGT2B27P is also thought to be involved in the regulation of cellular processes that are important for the survival and growth of cells. This gene has been shown to be involved in the regulation of cell death, cell cycle progression, and apoptosis, which are important processes that are involved in the regulation of cellular growth and development.

Because UGT2B27P is involved in the detoxification of xenobiotics and in the regulation of cellular processes, it is thought to be a potential drug target or biomarker for the treatment of a wide variety of diseases, including cancer. For example, studies have shown that UGT2B27P is downregulated in many types of cancer, and that inhibiting this gene may be an effective way to treat these diseases.

In addition to its potential as a drug target or biomarker, UGT2B27P is also of interest as a potential therapeutic agent for the treatment of a wide variety of other diseases. For example, because UGT2B27P is involved in the detoxification of xenobiotics, it may be useful for the treatment of diseases caused by exposure to these substances, such as cancer, neurotoxicity, and reproductive problems.

Overall, the UGT2B27P gene is a promising candidate as a drug target or biomarker for the treatment of a wide variety of diseases. Further research is needed to fully understand the role of this gene in the detoxification of xenobiotics and the regulation of cellular processes, as well as its potential as a therapeutic agent for the treatment of disease.

Protein Name: UDP Glucuronosyltransferase Family 2 Member B27, Pseudogene

The "UGT2B27P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UGT2B27P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets